In this cycle, tumor cell killing by TS-PDT promotes the release of neoantigens and induction of DAMPs (step 1), and anti-PD-1/PD-L1 pathway blockage induces killing of cancer cells by T cells (step 7). Here, CD274 is linked to neoplasm.